Stock IKT INHIBIKASE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Inhibikase Therapeutics, Inc.

Equities

IKT

US45719W2052

Market Closed - Nasdaq
Other stock markets
 21:30:01 28/06/2024 BST 		5-day change 1st Jan Change
1.21 USD -11.68% Intraday chart for Inhibikase Therapeutics, Inc. -13.57% -4.72%
06-17 Inhibikase Therapeutics Completes Enrollment of the Phase 2 ?201? Trial Evaluating Risvodetinib in Untreated Parkinson?s Disease CI
06-05 Inhibikase Therapeutics, Inc. Announces Expansion to Its Therapeutic Pipeline CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
INHIBIKASE THERAPEUTICS, INC. Stock Inhibikase Therapeutics, Inc.
 8.73M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 45.51B -
LONZA GROUP AG Stock Lonza Group AG
 39.36B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 38.52B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 30.74B -
CELLTRION, INC. Stock Celltrion, Inc.
 26.03B
  1. Stock Market
  2. Equities
  3. IKT Stock
  4. Charts Inhibikase Therapeutics, Inc.
  5. Sector Chart